| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 667909 | Null | 0.035202825328704 | 0.42204903 |
| NSC 669517 | Null | 0.035202825328704 | 0.43413487 |
| NSC 682817 | 7,10:11,14-Dietheno-28H-23,27-nitrilo-22H-dibenzo[b,p] [1,18,5,14]dioxadiazacyclopentacosine | 0.035202825328704 | -0.18670637 |
| NSC 700862 | 4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- | 0.035202825328704 | 0.5223245 |
| NSC 718630 | Null | 0.035202825328704 | 0.37507137 |
| NSC 720320 | 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole | 0.035202825328704 | -0.0066297818 |
| NSC 724783 | [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 | 0.035202825328704 | 0.44394206 |
| NSC 726217 | Combretastatin A4-analogue | 0.035202825328704 | 0.12461023 |
| NSC 728078 | 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide | 0.035202825328704 | 0.50582666 |
| NSC 732205 | Null | 0.035202825328704 | 0.5209863 |